|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/519 | |
| A61K 31/7068 | |||
| A61K 9/00 | |||
| A61P 35/00 | |||
| A61K 9/20 | |||
| A61K 9/48 |
| (11) | Number of the document | 2654755 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11851046.0 |
| Date of filing the European patent application | 2011-12-20 | |
| (97) | Date of publication of the European application | 2013-10-30 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/066017 |
| Date | 2011-12-20 |
| (87) | Number | WO 2012/088030 |
| Date | 2012-06-28 |
| (30) | Number | Date | Country code |
| 201061424961 P | 2010-12-20 | US |
| (72) |
DEMARINI, Douglas, J., US
LE, Ngocdiep, T., US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | Combination therapy comprising Gemcitabine for the treatment of pancreatic cancer |
| Combination therapy comprising Gemcitabine for the treatment of pancreatic cancer |